In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $13.32 down -8.20% from its previous closing price of $14.51. In other words, the price has decreased by -$8.20 from its previous closing price. On the day, 1.19 million shares were traded. SPRY stock price reached its highest trading level at $14.395 during the session, while it also had its lowest trading level at $13.26.
Ratios:
For a deeper understanding of ARS Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 02 ’24 when Chakma Justin bought 45,000 shares for $14.51 per share.
Shawver Laura bought 200,000 shares of SPRY for $2,713,000 on Dec 02 ’24. On Dec 02 ’24, another insider, ERIC KARAS, who serves as the Officer of the company, bought 3,717 shares for $14.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1294510848 and an Enterprise Value of 1087948672. For the stock, the TTM Price-to-Sale (P/S) ratio is 503.01 while its Price-to-Book (P/B) ratio in mrq is 6.44. Its current Enterprise Value per Revenue stands at 423.656 whereas that against EBITDA is -17.999.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $4.76. The 50-Day Moving Average of the stock is -9.95%, while the 200-Day Moving Average is calculated to be 19.58%.
Shares Statistics:
For the past three months, SPRY has traded an average of 1.05M shares per day and 969640 over the past ten days. A total of 97.15M shares are outstanding, with a floating share count of 50.84M. Insiders hold about 47.79% of the company’s shares, while institutions hold 42.07% stake in the company. Shares short for SPRY as of 1731628800 were 13852113 with a Short Ratio of 13.14, compared to 1728950400 on 11915667. Therefore, it implies a Short% of Shares Outstanding of 13852113 and a Short% of Float of 26.8.
